Development and Validation of Novel Residual Risk Scores for Patients With ASCVD is a research paper published in JACC Advances (2025). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Heart Association Inc
Grant: 17IGMV33860009
NHLBI NIH HHS
Grant: R21 HL167173
Swiss Data Science Center
Grant: 2022-812
National Human Genome Research Institute
Grant: U01HG008685
NHLBI NIH HHS
Grant: K01 HL135342
NHLBI NIH HHS
Grant: K24 HL136852
National Heart, Lung, and Blood Institute
Grant: R21 HL156174
NIH
École Polytechnique Fédérale de Lausanne
Swiss Federal Institute of Technology Zurich
Brigham and Women's Hospital
Max Planck ETH Center for Learning Systems
Keywords